Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.690
-0.100 (-5.59%)
May 29, 2026, 4:00 PM EST
Cardiol Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Cardiol Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $6.00. The average 1-year stock price forecast is 255.03% higher than the current stock price, while the lowest is $5.00 (+195.86%) and the highest is $7.00 (+314.20%).
Price Target: $6.00 (+255.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cardiol Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $11.05 | Buy | Reiterates | $11.05 | +553.64% | May 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12.43 | Buy | Reiterates | $12.43 | +635.35% | May 12, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.